IGF1R and breast cancer: In order to determine if targeting different components of the IGF-1/RhoA/ROCK crosstalk between BC cells and CAFs would affect primary tumor growth and metastasis, we treated MDA-MB-231 xenografts with the IGF-1R inhibitor PQ401 [34], Y27632 or PQ401 combined with Y27632.